首页> 外文期刊>Clinical Medicine Insights: Gastroenterology >Surgical Management of Adenocarcinoma of the Pancreatic Uncinate Process in a Cancer Hospital in Egypt
【24h】

Surgical Management of Adenocarcinoma of the Pancreatic Uncinate Process in a Cancer Hospital in Egypt

机译:埃及一家癌症医院的胰腺癌变过程腺癌的外科治疗

获取原文
           

摘要

Introduction: Pancreatic carcinoma affecting the uncinate process is a challenging surgical condition. Several considerations affect the management plan, including the need for vascular resection and the ability to achieve a clear margin.Methods: The data of 19 patients who had curative resection for pancreatic adenocarcinoma of the uncinate process were reviewed. Operative mortality and morbidity, and disease-free survival (DFS) were calculated.Results: The study population included 13 male and 6 female patients with a mean age of 55 years. Nine patients (47.4%) had stage I disease, seven patients (36.8%) had stage II disease, and three patients (15.8%) had stage III disease. A total of 12 patients had Whipple procedure and 7 patients had total pancreatectomy. In total, there were 9 R0 and 10 R1 resections. Operative mortality rate was 10.5% (2/19), postoperative leakage rate was 21.1% (4/19), and wound sepsis rate was 21.1%. Median DFS was 19.2 months. Survival was superior in the Whipple procedure group than in the total pancreatectomy group (median survival 19 months vs 4 months, respectively). Vascular resection and retroperitoneal safety margin status did not affect disease relapse.Conclusion: Non-metastatic pancreatic adenocarcinoma of the uncinate process should be offered R0 or R1 resection whenever technically feasible.
机译:简介:影响癌变过程的胰腺癌是具有挑战性的手术条件。方法:对19例单发性胰腺癌进行根治性切除的患者资料进行了回顾性分析,这些因素影响了治疗计划,其中包括需要进行血管切除和达到明确的切缘。结果:研究人群包括13名男性和6名女性患者,平均年龄为55岁。 9例(47.4%)患有I期疾病,7例(36.8%)患有II期疾病,3例(15.8%)患有III期疾病。共有12例患者进行了Whipple手术,而7例患者进行了全胰腺切除术。总共有9个R0和10个R1切除。手术死亡率为10.5%(2/19),术后渗漏率为21.1%(4/19),伤口败血症率为21.1%。 DFS中位数为19.2个月。 Whipple手术组的生存率优于全胰腺切除术组(中位生存期分别为19个月和4个月)。血管切除术和腹膜后安全裕度状态不影响疾病复发。结论:在技术可行的情况下,应为R0或R1切除提供非融合过程的非转移性胰腺腺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号